Quidel | QDEL - Assets


Quidel reported $5.63B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.07B 252M Mar/2026
Avanos Medical USD 1.05B 23.6M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Cerus USD 221.86M 6.67M Dec/2025
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Danaher USD 83.54B 80M Mar/2026
Haemonetics USD 2.4B 94.96M Mar/2026
Illumina USD 6.56B 85M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Merit Medical Systems USD 2.72B 33.36M Mar/2026
Mettler Toledo International USD 3.67B 43.73M Mar/2026
Myriad Genetics USD 673.7M 32.9M Mar/2026
Neogen USD 3.36B 953K Dec/2025
OraSure Technologies USD 379.17M 24M Mar/2026
Pacific Biosciences Of California USD 782.36M 1.72M Mar/2026
Quidel USD 5.63B 140.6M Mar/2026
Revvity USD 12B 171.82M Mar/2026
STAAR Surgical USD 451.12M 560K Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Waters USD 24.53B 19.45B Mar/2026